A data monitoring committee recommended stopping FLASH2, a randomized double-blind placebo-controlled confirmatory phase 3 ...
Madhu Gaganam, founder and CEO of Cogniedge.ai, said the industry’s shift toward cobots demands more than safer cages or ...
As CAR T-cell therapy reaches community oncology, practice leaders discuss the challenges of payer hurdles, single case ...
The problem of demand outstripping supply capacity is a tale that has become all-too-common across the major AI providers.
RNA rewards companies that can integrate biology, data science, manufacturing, and clinical development into a single ...
Organoids and engineered systems are transforming malaria research, improving drug discovery and understanding of Plasmodium ...
Industry analysts say faster construction timelines, along with lower energy costs, are fueling consistent growth in a solar ...
The FDA began accepting live AI and cloud data feeds from AstraZeneca's TRAVERSE and Amgen's STREAM-SCLC oncology trials, ...
A new study links the sun's 11-year cycle to accelerated orbital loss, with debris falling faster once sunspot numbers near ...
How do our genes determine our appearance and our susceptibility to disease? This question is central to biomedical research, ...
More than half a billion people worldwide are living with diabetes, the vast majority with type 2 diabetes (T2D), a chronic ...
An international team of astronomers has analyzed the data from the James Webb Space Telescope (JWST) and Atacama Large ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results